IMNM – immunome, inc. (US:NASDAQ)
Stock Stats
News
Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Immunome, Inc. (NASDAQ: IMNM) had its price target lowered by analysts at Piper Sandler from $23.00 to $21.00. They now have an "overweight" rating on the stock.
Immunome, Inc GAAP EPS of -$0.78 misses by $0.21 [Seeking Alpha]
Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update
Immunome to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
Form SC 13G/A Immunome Inc. Filed by: Redmile Group, LLC
Form SC 13G Immunome Inc. Filed by: T. Rowe Price Investment Management, Inc.
Form SC 13G Immunome Inc. Filed by: JANUS HENDERSON GROUP PLC
Form 10-Q Immunome Inc. For: Sep 30
Form 8-K Immunome Inc. For: Nov 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.